Department of Thoracis Surgery 2, Gansu Provincial Hospital, Lanzhou, China.
Department of Clinical Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, China.
Neoplasma. 2020 Jul;67(4):751-761. doi: 10.4149/neo_2020_190805N717. Epub 2020 Apr 16.
Esophageal squamous cell carcinoma (ESCC) is a major subtype of esophageal cancer with high mortality. Previous reports suggested that lncRNA taurine upregulated gene 1 (TUG1) functioned as an oncogene in numerous cancers. The purpose of this study was to explore the potential mechanism of TUG1 carcinogenesis in ESCC. The expression of TUG1 and miR-498 was measured by a quantitative real-time polymerase chain reaction (qRT-PCR). Cell proliferation and apoptosis were assessed by 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay and flow cytometry. Cell migration and invasion were identified through the transwell assay. The interaction between miR-498 and TUG1 or X-box binding protein 1 (XBP1) was predicted by bioinformatics software starBase and verified by luciferase reporter assay. The expression of XBP1 was quantified by qRT-PCR and western blot analysis. Xenograft tumor mouse model was established to determine the function of TUG1 in vivo. TUG1 was upregulated in ESCC tissues and cells, and its high expression was associated with tumor lymph node metastasis and low cumulative survival. TUG1 knockdown inhibited proliferation, migration, and invasion but promoted apoptosis in ESCC cells. It was confirmed that miR-498 was a target of TUG1, and XBP1 was a target of miR-498. The expression of miR-498 was reduced in ESCC tissues while XBP1 expression was notably enhanced. Mechanism analysis manifested that TUG1 regulated proliferation, apoptosis, migration, and invasion by upregulating XBP1 via targeting miR-498 in vitro. Furthermore, knockdown of TUG1 attenuated tumor growth in vivo. TUG1 accelerated tumorigenesis and metastasis by inducing XBP1 expression through directly targeting miR-498 in ESCC.
食管鳞状细胞癌 (ESCC) 是食管癌的主要亚型,死亡率较高。先前的报告表明,长链非编码 RNA 牛磺酸上调基因 1 (TUG1) 在许多癌症中发挥癌基因作用。本研究旨在探讨 TUG1 在 ESCC 发生发展中的潜在机制。通过实时定量聚合酶链反应 (qRT-PCR) 测量 TUG1 和 miR-498 的表达。通过 3-(4,5-二甲基-2-噻唑基)-2,5-二苯基-2-H-四唑溴盐 (MTT) 测定和流式细胞术评估细胞增殖和凋亡。通过 Transwell 测定鉴定细胞迁移和侵袭。通过生物信息学软件 starBase 预测 miR-498 与 TUG1 或 X 框结合蛋白 1 (XBP1) 之间的相互作用,并通过荧光素酶报告基因测定进行验证。通过 qRT-PCR 和 Western blot 分析定量 XBP1 的表达。建立异种移植肿瘤小鼠模型以确定 TUG1 在体内的功能。TUG1 在 ESCC 组织和细胞中上调,其高表达与肿瘤淋巴结转移和低累积生存率相关。TUG1 敲低抑制 ESCC 细胞的增殖、迁移和侵袭,但促进凋亡。证实 miR-498 是 TUG1 的靶标,XBP1 是 miR-498 的靶标。miR-498 在 ESCC 组织中的表达降低,而 XBP1 的表达明显增强。机制分析表明,TUG1 通过靶向 miR-498 上调 XBP1 来调节体外增殖、凋亡、迁移和侵袭。此外,TUG1 的敲低减弱了体内肿瘤的生长。TUG1 通过直接靶向 miR-498 诱导 XBP1 表达,从而加速 ESCC 的肿瘤发生和转移。